James P. McCafferty

1.3k total citations
21 papers, 518 citations indexed

About

James P. McCafferty is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, James P. McCafferty has authored 21 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 7 papers in Pharmacology and 6 papers in Experimental and Cognitive Psychology. Recurrent topics in James P. McCafferty's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers), Treatment of Major Depression (6 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). James P. McCafferty is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers), Treatment of Major Depression (6 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). James P. McCafferty collaborates with scholars based in United States, United Kingdom and Norway. James P. McCafferty's co-authors include Kevin M. Bellew, Malini Iyengar, Rocco Zaninelli, Daniel B. Burnham, Andrew W. Goddard, Mark H. Pollack, Karl Rickels, David V. Sheehan, I. Gergel and Robert G. Pendleton and has published in prestigious journals such as Journal of the American College of Cardiology, American Journal of Psychiatry and Biological Psychiatry.

In The Last Decade

James P. McCafferty

20 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James P. McCafferty United States 7 294 206 184 108 57 21 518
David E. Wheadon United States 9 220 0.7× 224 1.1× 175 1.0× 157 1.5× 55 1.0× 11 454
Laura A. Mandos United States 12 300 1.0× 121 0.6× 241 1.3× 214 2.0× 93 1.6× 19 568
P. M. Manniche Denmark 7 217 0.7× 118 0.6× 219 1.2× 157 1.5× 58 1.0× 11 400
P. Tanghøj Denmark 11 156 0.5× 97 0.5× 313 1.7× 285 2.6× 55 1.0× 18 653
Charles S. Wilcox United States 16 272 0.9× 171 0.8× 320 1.7× 275 2.5× 127 2.2× 27 806
I. Benattia United States 10 107 0.4× 294 1.4× 263 1.4× 247 2.3× 61 1.1× 18 678
Klerman Gl United States 11 115 0.4× 87 0.4× 170 0.9× 177 1.6× 89 1.6× 24 510
K. Hewett United Kingdom 7 130 0.4× 70 0.3× 158 0.9× 101 0.9× 48 0.8× 11 324
Ballenger Jc United States 15 135 0.5× 99 0.5× 109 0.6× 327 3.0× 128 2.2× 19 650
Ayako Kaneda Japan 15 99 0.3× 94 0.5× 80 0.4× 167 1.5× 56 1.0× 42 533

Countries citing papers authored by James P. McCafferty

Since Specialization
Citations

This map shows the geographic impact of James P. McCafferty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. McCafferty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. McCafferty more than expected).

Fields of papers citing papers by James P. McCafferty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. McCafferty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. McCafferty. The network helps show where James P. McCafferty may publish in the future.

Co-authorship network of co-authors of James P. McCafferty

This figure shows the co-authorship network connecting the top 25 collaborators of James P. McCafferty. A scholar is included among the top collaborators of James P. McCafferty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. McCafferty. James P. McCafferty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCafferty, James P., et al.. (2016). Ransomware Recovery. ITNOW. 58(4). 32–33. 5 indexed citations
2.
Rickels, Karl, Rocco Zaninelli, James P. McCafferty, et al.. (2003). Paroxetine Treatment of Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study. American Journal of Psychiatry. 160(4). 749–756. 145 indexed citations
3.
Keller, Martín & James P. McCafferty. (2002). Paroxetine In The Treatment Of Adolescent Major Depression: Dr. Keller and Mr. McCafferty reply. Journal of the American Academy of Child & Adolescent Psychiatry. 41(11). 1270–1270.
4.
Pollack, Mark H., Rocco Zaninelli, Andrew W. Goddard, et al.. (2001). Paroxetine in the Treatment of Generalized Anxiety Disorder. The Journal of Clinical Psychiatry. 62(5). 350–357. 197 indexed citations
5.
Baldwin, David S., et al.. (2001). Improving the impairment and disability associated with generalised anxiety disorder with paroxetine treatment. European Neuropsychopharmacology. 11. S309–S309. 2 indexed citations
6.
McCafferty, James P., et al.. (2000). Paroxetine is effective in the treatment of generalized anxiety disorder: results from a randomized placebo-controlled flexible dose study. European Neuropsychopharmacology. 10. 347–348. 2 indexed citations
7.
Nelson, J. Craig, John Kennedy, Bruce G. Pollock, et al.. (1999). Treatment of Major Depression With Nortriptyline and Paroxetine in Patients With Ischemic Heart Disease. American Journal of Psychiatry. 156(7). 1024–1028. 76 indexed citations
8.
McCafferty, James P., et al.. (1998). Paroxetine: The preferred choice of patients in the treatment of depression. European Neuropsychopharmacology. 8. S159–S159. 1 indexed citations
9.
Tylee, André, James P. McCafferty, & I. Gergel. (1998). Depression comorbid with medical illness — Treatment with paroxetine. European Neuropsychopharmacology. 8. S159–S160. 1 indexed citations
10.
Roose, Steven P., et al.. (1997). Paroxetine in the treatment of depressed patients with ischaemic heart disease. Biological Psychiatry. 42(1). 243S–243S. 3 indexed citations
11.
Finkel, Mitchell S., Fouzia Laghrissi‐Thode, Bruce G. Pollock, et al.. (1996). Randomized trial of antidepressants in patients with ischemic heart disease. Journal of the American College of Cardiology. 27(2). 186–186. 1 indexed citations
12.
Clark, Michael, et al.. (1996). Muscarinic partial agonists in the symptomatic treatment of Alzheimer's Disease. European Neuropsychopharmacology. 6. 30–30. 3 indexed citations
13.
Hieble, J. Paul, Anthony C. Sulpizio, Henry M. Sarau, et al.. (1989). SK&F 89124, A POTENT AND SELECTIVE AGONIST AT PREJUNCTIONAL DOPAMINE RECEPTORS. Fundamental and Clinical Pharmacology. 3(6). 621–642. 3 indexed citations
14.
McCafferty, James P., et al.. (1986). Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat.. PubMed. 236(1). 1–7. 21 indexed citations
15.
McCafferty, James P., et al.. (1986). Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-2 antagonist, in the rat.. Journal of Pharmacology and Experimental Therapeutics. 236(1). 1–7. 2 indexed citations
16.
Hill, David T., et al.. (1983). 1,3-Diaryltriazenes: a new class of anorectic agents. Journal of Medicinal Chemistry. 26(6). 865–869. 21 indexed citations
17.
Hieble, J. Paul, James P. McCafferty, Robert G. Pendleton, et al.. (1983). Cardiovascular Activity of SK&F 64139 in the Hypertensive Rat. Journal of Cardiovascular Pharmacology. 5(5). 889–897. 2 indexed citations
18.
McCafferty, James P., et al.. (1981). Studies on the mechanisms involved in the cardiovascular response of the rat to hemorrhage.. PubMed. 254(1). 58–69. 3 indexed citations
19.
Pendleton, Robert G., et al.. (1981). Mechanism for gastric antisecretory effects of desmethylimipramine in rats. European Journal of Pharmacology. 75(4). 171–178. 12 indexed citations
20.
Pendleton, Robert G., et al.. (1980). The effects of PNMT inhibitors upon cardiovascular changes induced by hemorrhage in the rat. European Journal of Pharmacology. 66(1). 1–10. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David E. Wheadon Breakdown of academic impact, for papers by Laura A. Mandos Breakdown of academic impact, for papers by P. M. Manniche Breakdown of academic impact, for papers by P. Tanghøj Breakdown of academic impact, for papers by Charles S. Wilcox Breakdown of academic impact, for papers by I. Benattia Breakdown of academic impact, for papers by Klerman Gl Breakdown of academic impact, for papers by K. Hewett Breakdown of academic impact, for papers by Ballenger Jc Breakdown of academic impact, for papers by Ayako Kaneda
Rankless by CCL
2026